1. Sun, Jian, Wang, Fei, Zhou, Huihui, Fan, Caibin, Wang, Jianqing. 2022. Downregulation of PGM5 expression correlates with tumor progression and poor prognosis in human prostate cancer. In Discover oncology, 13, 63. doi:10.1007/s12672-022-00525-x. https://pubmed.ncbi.nlm.nih.gov/35819729/
2. Duan, Xiaoyu, Wang, Lingdian, Wang, Zhifeng, Wang, Miao, Ding, Degang. . LncRNA PGM5-AS1 Inhibits the Progression of Bladder Cancer by Regulating miR-587/SLIT3 Axis. In Critical reviews in eukaryotic gene expression, 32, 9-22. doi:10.1615/CritRevEukaryotGeneExpr.2022042376. https://pubmed.ncbi.nlm.nih.gov/36017912/
3. Shen, Yang, Qi, Liping, Li, Yu, Zhu, Yixiang, Wang, Kuanyu. 2020. The Downregulation of lncRNA pgm5-as1 Inhibits the Proliferation and Metastasis Via Increasing miR-484 Expression in Colorectal Cancer. In Cancer biotherapy & radiopharmaceuticals, 36, 220-229. doi:10.1089/cbr.2019.3059. https://pubmed.ncbi.nlm.nih.gov/32354224/
4. Du, Lei, Gao, Yongli. 2021. PGM5-AS1 impairs miR-587-mediated GDF10 inhibition and abrogates progression of prostate cancer. In Journal of translational medicine, 19, 12. doi:10.1186/s12967-020-02572-w. https://pubmed.ncbi.nlm.nih.gov/33407592/
5. Wang, Huimin, Wang, Dan, Wei, Qiong, Li, Chunyan, Yang, Jing. . Long non-coding RNAs PGM5-AS1 upregulates Decorin (DCN) to inhibit cervical cancer progression by sponging miR-4284. In Bioengineered, 13, 9872-9884. doi:10.1080/21655979.2022.2062088. https://pubmed.ncbi.nlm.nih.gov/35420507/
6. Wang, Jiajun, Ye, Jun, Dang, Yuxue, Xu, Shun. 2024. LncRNA PGM5-AS1 inhibits non-small cell lung cancer progression by targeting miRNA-423-5p/SLIT2 axis. In Cancer cell international, 24, 216. doi:10.1186/s12935-024-03402-5. https://pubmed.ncbi.nlm.nih.gov/38902704/
7. Ran, Fang, Zhang, Yanan, Shi, Yajiao, Ding, Lihua, Ye, Qinong. 2021. miR-1224-3p Promotes Breast Cancer Cell Proliferation and Migration through PGM5-Mediated Aerobic Glycolysis. In Journal of oncology, 2021, 5529770. doi:10.1155/2021/5529770. https://pubmed.ncbi.nlm.nih.gov/33986801/
智鼠故事 
